A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer.
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- O'Connor et al. 2007... Phase I clinical trial.pdf
- Size:
- 291.31 KB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 3.42 KB
- Format:
- Item-specific license agreed upon to submission
- Description: